Boehringer Ingelheim

Highly Engaged Employees

Boehringer Ingelheim, founded in 1885, is a prominent, privately held, research-driven pharmaceutical entity. The company specializes in the development and manufacturing of prescription medicines and healthcare solutions across three primary business segments: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Its therapeutic portfolio focuses on critical areas including oncology, immunology, respiratory diseases, cardiometabolic conditions, and central nervous system disorders. By prioritizing R&D, the firm maintains a robust pipeline of innovative therapies designed to address unmet medical needs globally.

Operating with a workforce of over 10,000 employees, Boehringer Ingelheim maintains an extensive international footprint with research, manufacturing, and commercial sites spanning Europe, North America, and Asia. The organization leverages its scale to drive advancements in veterinary medicine for companion animals, livestock, and poultry, alongside its human health initiatives. Meet Boehringer Ingelheim's team to understand the leadership structure and the specialized talent driving these complex scientific operations. The company’s commitment to high-standard manufacturing processes ensures consistent delivery of active pharmaceutical ingredients and complex biopharmaceutical products to global markets.

With annual revenue reaching $31.4B, Boehringer Ingelheim stands as one of the largest privately owned pharmaceutical companies worldwide. The firm’s strategic focus on long-term growth is supported by significant investment in discovery and development, ensuring a competitive edge in the global healthcare landscape. Explore financial highlights to review the company's fiscal performance, funding history, and market positioning. Through its integrated business model, the company continues to pioneer health solutions that improve patient outcomes and community well-being across diverse geographic regions.